Maria Gonzalez-Cao

17PUBLICATIONS
91CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)AllergyNanomedicinePeople with disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 06, 2026
Beyond BRAF V600: emerging MAPK-targeted therapeutic strategies.

|Jul 24, 2026
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.

|Aug 21, 2025
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry.

Maria Gonzalez-Cao, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo

|Jun 27, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.

Iván Márquez-Rodas, Caroline Dutriaux, Philippe Saiag

|Jul 01, 2024
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.

Pablo Cerezuela-Fuentes, Maria Gonzalez-Cao, Teresa Puertolas

|May 15, 2024
Access to melanoma drugs in Spain: a cross-sectional survey.

Maria Gonzalez-Cao, Teresa Puertolas, Jose Luis Manzano

Pageof 3

Frequent Collaborators

3 joint publications

Mario Mandalà

3 joint publications

Ana Arance

2 joint publications

Paolo A Ascierto

2 joint publications

Pier Francesso Ferrucci